CYTK — Cytokinetics, Incorporated Share News
0.000.00%
Last trade - 00:00- $8.89bn
- $8.87bn
- $88.04m
NASDAQ TRADE HALT HALT NEWS PENDING AT 01:50 PM
U.S. STOCKS ON THE MOVE-Robinhood Markets, Cannabis stocks, Hyatt Hotels
U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks
U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse
Cytokinetics rises after winning China approval for heart disease drug
Brief: Cytokinetics Announces Nmpa Approval Of Myqorzo® In China
Brief: EMA's CHMP Recommended Granting Marketing Authorisation For Moderna's Mnexspike
Brief: Cytokinetics Announces Positive CHMP Opinion Of MYQORZO For The Treatment Of Obstructive Hypertrophic Cardiomyopathy
Brief: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Cytokinetics Supports American Heart Association Initiative To Improve Care For People Living With Hypertrophic Cardiomyopathy
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Brief: Cytokinetics To Announce Third Quarter Results On November 5, 2025
Brief: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Cytokinetics Presents New Data Related To Aficamten
Brief: Cytokinetics Announces Call For Proposals For Its Eighth Annual Communications Grant Program
Advisory: Alert from law firm tagged to Cytokinetics withdrawn
Brief: Cytokinetics Announces Inducement Grants
Brief: Cytokinetics Announces Three Upcoming Presentations At The HFSA Annual Scientific Meeting 2025
U.S. STOCKS ON THE MOVE-Regeneron, Elf Beauty, Eli Lilly